We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong’s Latest All-in-one Molecular Diagnosis system - Panall 8000 Open System

By LabMedica International staff writers
Posted on 14 May 2024

New achievement! More...

We are excited to announce that Tianlong’s Panall 8000 All-in-one Molecular Diagnosis system is now OPEN to be compatible with PCR reagents from different manufacturers. The open system now enables laboratories to program user-defined PCR analysis protocols, and allows you to test a wide range of sample types and meet emerging diagnostic requirements through customized reagents.

Tianlong Panall 8000 is an open system that enables laboratories to program user-defined PCR analysis protocols. Laboratories can use user-defined protocols in addition to those developed by Tianlong. The simple and efficient design of the Tianlong Panall 8000 allows you to test a wide range of sample types and meet emerging diagnostic requirements through customized reagents. Tianlong intends to work with our partners to bring more new tests to the Panall 8000 for detection of a broad range of disease categories.

Features of Panall 8000 Open System:

Compatible with PCR reagents from different manufacturers:
Empty PCR tubes work with your PCR reagents

Customize collaboration mode for a more diversified menu
Tianlong will collaborate with our partners to jointly expand the testing menu. Tianlong can customize nucleic acid extraction reagents to match your PCR reagents for more business possibilities.

Available for more application scenarios
An open system with a diversified testing menu can meet your emerging diagnostic reguirements and apply in more scenarios. Tianlong Panall 8000 compatible with your reagents can optimize the detection process with minimal hands-on time and make detection more efficient

Extensive Testing Menu: Respiratory infection, Gastrointestinal infections, Sexually transmitted infections, and Customized reagents

Learn more about Tianlong’s Panall 8000:
https://www.medtl.net/products/open-system-panall-8000-all-in-one-molecular-diagnosis-system.html

#IVD #PCR #Health #MolecularDiagnostics #GeneticTesting



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Electrolyte Analyzer
BKE-B
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The mRNA Gene Biomarker Test uses standard blood samples to generate a probability score distinguishing schizophrenia from bipolar I disorder (photo courtesy of Laguna Diagnostics)

Blood Test Receives FDA Breakthrough Status to Differentiate Schizophrenia and Bipolar Disorder

Differentiating schizophrenia from bipolar I disorder in symptomatic patients is challenging because early presentations often overlap. Current diagnostic pathways rely heavily on subjective assessments... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.